Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87M
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
67.6M
-
Shares change
-
-949K
-
Total reported value, excl. options
-
$1.41B
-
Value change
-
-$33.8M
-
Put/Call ratio
-
0.35
-
Number of buys
-
84
-
Number of sells
-
-64
-
Price
-
$20.85
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q2 2021
190 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.6M shares
of 87M outstanding shares and own 77.72% of the company stock.
Largest 10 shareholders include FMR LLC (7.8M shares), BlackRock Inc. (4.96M shares), Avoro Capital Advisors LLC (4.14M shares), EcoR1 Capital, LLC (3.72M shares), VANGUARD GROUP INC (3.28M shares), STATE STREET CORP (3.25M shares), Holocene Advisors, LP (2.59M shares), AMERIPRISE FINANCIAL INC (2.48M shares), WELLINGTON MANAGEMENT GROUP LLP (2.11M shares), and Foresite Capital Management IV, LLC (1.85M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.